Eric G. Carter - Mar 19, 2024 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role: Director
Signature: /s/ Alexander Wilson as attorney-in-fact for Eric G. Carter
Stock symbol: AEON
Transactions as of: Mar 19, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/21/2024, 07:45 PM
Previous filing: Aug 16, 2023
Next filing: Sep 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AEON	Stock Option	Award	$0	+16.3K		$0.00	16.3K	Mar 19, 2024	Common Stock	16.3K	$14.40	Direct	F1
transaction	AEON	Stock Option	Award	$0	+8.13K		$0.00	8.13K	Mar 19, 2024	Common Stock	8.13K	$14.40	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of stock options granted on March 19, 2024 (the "Grant Date"), which vests in substantially equal monthly installments over the one year following the Grant Date, subject to the reporting person's continued service through the applicable vesting date. Option will vest in full upon a Change in Control (as defined in the AEON Biopharma Inc. 2023 Incentive Award Plan) of the Company.
F2	Represents an award of stock options granted on March 19, 2024 (the "Grant Date"), which vests in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.

Content

Represents an award of stock options granted on March 19, 2024 (the "Grant Date"), which vests in substantially equal monthly installments over the one year following the Grant Date, subject to the reporting person's continued service through the applicable vesting date. Option will vest in full upon a Change in Control (as defined in the AEON Biopharma Inc. 2023 Incentive Award Plan) of the Company.

Represents an award of stock options granted on March 19, 2024 (the "Grant Date"), which vests in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.